Reports for SUN PHARMA CANADA INC
Company Name
SUN PHARMA CANADA INC
Totals |
||
Shortage reports |
359 |
|
| Actual shortage: | 22 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 331 (92%) | |
Discontinuation Reports |
33 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 33 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
208 (53%) |
|
Overdue reports |
1 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-DONEPEZIL | 5MG | TABLET | Resolved | 2017-03-13 | 2019-02-01 | 1387 |
| TARO-DONEPEZIL | 5MG | TABLET | Resolved | 2017-03-13 | 2019-02-01 | 1399 |
| TARO-DONEPEZIL | 5MG | TABLET | Resolved | 2020-03-07 | 2021-08-04 | 108158 |
| TARO-DONEPEZIL | 5MG | TABLET | Resolved | 2021-05-01 | 2021-06-16 | 138438 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2017-05-10 | 2018-11-28 | 9992 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2019-02-11 | 2019-05-29 | 75277 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2019-02-11 | 2019-05-28 | 75280 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-01-28 | 2020-03-07 | 104609 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-01-28 | 2020-07-03 | 104612 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2021-01-31 | 2021-05-04 | 132997 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2023-08-24 | 2024-01-05 | 202875 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2023-08-24 | 2024-01-05 | 202878 |
| TARO-SOLIFENACIN | 5MG | TABLET | Resolved | 2018-03-22 | 2019-02-01 | 43668 |
| TARO-SOLIFENACIN | 5MG | TABLET | Resolved | 2019-10-04 | 2019-10-12 | 95482 |
| TARO-SOLIFENACIN | 5MG | TABLET | Resolved | 2020-01-04 | 2020-02-24 | 102369 |
| TARO-SOLIFENACIN | 5MG | TABLET | Actual shortage | 2023-08-25 | 2024-05-09 | 202932 |
| TARO-TADALAFIL | 5MG | TABLET | Resolved | 2017-11-30 | 2019-02-01 | 31239 |
| TARO-TADALAFIL | 5MG | TABLET | Resolved | 2019-09-03 | 2019-11-26 | 92851 |
| TARO-TADALAFIL | 5MG | TABLET | Resolved | 2020-05-27 | 2021-05-01 | 115884 |
| TARO-RAMIPRIL HCTZ | 5MG 25MG | TABLET | Resolved | 2020-04-20 | 2020-05-27 | 112534 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-ZOPICLONE | 7.5MG | TABLET | Discontinued | 2021-06-16 | 2021-06-17 | 141043 |
| TARO-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115038 |
| TARO-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115046 |
| TARO-DONEPEZIL | 5MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80060 |
| TARO-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2020-02-02 | 2020-02-02 | 105091 |
| TARO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91266 |
| TARO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91269 |
| TARO-PREGABALIN | 300MG | CAPSULE | Discontinued | 2020-05-27 | 2020-05-27 | 115811 |
| TARO-QUETIAPINE | 300MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80042 |
| TARO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80028 |
| TARO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2019-08-09 | 2019-08-10 | 91284 |
| TARO-QUETIAPINE | 25MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80031 |
| TARO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-03-07 | 2020-03-07 | 108133 |
| TARO-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115059 |
| TARO-PREGABALIN | 225MG | CAPSULE | Discontinued | 2019-10-04 | 2019-10-04 | 95487 |
| TARO-PREGABALIN | 225MG | CAPSULE | Discontinued | 2021-08-04 | 2021-08-04 | 143568 |
| TARO-PREGABALIN | 225MG | CAPSULE | Discontinued | 2021-08-24 | 2021-08-24 | 144544 |
| TARO-SIMVASTATIN | 20MG | TABLET | Discontinued | 2020-05-27 | 2020-05-27 | 115929 |
| TARO-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91261 |
| TARO-QUETIAPINE | 200MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80039 |